Logotype for Initiator Pharma

Initiator Pharma (INIT) investor relations material

Initiator Pharma Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Initiator Pharma
Q3 2025 earnings summary21 Nov, 2025

Executive summary

  • Focused on advancing a Phase IIa proof-of-concept study for pudafensine in vulvodynia, with regulatory approval and patient enrollment initiated in Q4 2025.

  • Successfully completed a rights issue in July, raising SEK 48.3 million before costs, and secured additional convertible financing for clinical trials.

  • Strategic emphasis on business development and partnering for clinical assets, with increased industry interest following BIO-EUROPE.

Financial highlights

  • No revenue generated in Q3 or the first nine months of 2025.

  • Operating loss for Q3 2025 was TDKK 4,318, up from TDKK 3,233 in Q3 2024, reflecting increased R&D and fundraising costs.

  • Net loss after tax for Q3 2025 was TDKK 3,864, with earnings per share at DKK -0.06; nine-month net loss was TDKK 6,517.

  • Cash and cash equivalents rose to TDKK 28,674 as of September 30, 2025, from TDKK 13,371 at year-end 2024.

  • Equity increased to TDKK 32,466 as of September 30, 2025, compared to TDKK 14,782 at year-end 2024.

Outlook and guidance

  • First patient dosing in the vulvodynia Phase IIa study expected before year-end 2025, with topline results anticipated by late 2026.

  • Continued focus on progressing clinical pipeline and attracting partners for further development and commercialization.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Initiator Pharma earnings date

Logotype for Initiator Pharma
Q4 202520 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Initiator Pharma earnings date

Logotype for Initiator Pharma
Q4 202520 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Initiator Pharma A/S is a Danish clinical-stage biopharmaceutical company focusing on developing treatments for unmet medical needs related to the central and peripheral nervous systems. The company’s portfolio primarily targets disorders such as erectile dysfunction (ED) and neuropathic pain. Its clinical programs include drug candidates for both psychogenic and organic ED as well as a rare disease program for Trigeminal Neuralgia, a chronic pain condition. Initiator Pharma leverages its expertise in monoamine reuptake inhibitors, which increase key neurotransmitters like dopamine to treat various neurological conditions. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Nasdaq Stockholm.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage